Array Biopharma (ARRY) Files $200M Mixed Shelf
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Join SI Premium – FREE
Array Biopharma, Inc. (NASDAQ: ARRY) filed a registration with the U.S. SEC to sell, from time to time, up to $200 million of Common Stock, Preferred Stock, Depositary Shares, Debt Securities, Warrants, Units, or any combination thereof.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fisker (FSR) files form 10-K, sees more job cuts, reiterates going concern doubts
- CSS Entertainment (CSSE) Receives Nasdaq Delinquency Letter
- Scilex Holding (SCLX) Prices 15M Share Offering at $1/sh
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
